Browse this journal

Latest articles

‘Latest articles’ are articles accepted for publication in this journal but not yet published in a volume/issue. Articles are removed from the ‘Latest articles’ list when they are published in a volume/issue. Latest articles are citable using the author(s), year of online publication, article title, journal and article DOI.

Download Citation Download PDFs

Letter to the Editor

Letter to the Editor
Successful treatment with belantamab mafodotin in a heavily pretreated patient with multiple myeloma and liver extramedullary disease
Nicola Sgherza, Paola Curci, Gabriella Di Carlo, Domenica Grande, Alessandro Capozzi, Giuseppe Ingravallo, Luca De Marco, Paolo Ferreri & Pellegrino Musto
Published online: 08 Jun 2024
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric

Review Article

Review Article
Advances in the treatment of adults with newly diagnosed B-cell acute lymphoblastic leukemia: the role of frontline immunotherapy-based regimens
Nicholas J. Short, Hagop Kantarjian & Elias Jabbour
Published online: 08 Jun 2024
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care)
Ombretta Annibali, Alessia Castellino, Natalia Cenfra, Mariavita Ciccarone, Francesco Rotondo, Carla Minoia, Luigi Petrucci, Guido Gini, Chiara Rusconi, Valentina Bozzoli, Maura Nicolosi, Gloria Margiotta, Erika Meli, Federica Cocito, Sara Bigliardi, Sabino Ciavarella, Cristiano Tesei, Francesco Zaja & On behalf of the Fondazione Italiana Linfomi Postgraduate Master Course
Published online: 07 Jun 2024
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia
Kriti Gera, Christina Cline, Zeina Al-Mansour, Andrew Medvec, Ji-Hyun Lee, Zhanna Galochkina, Jack Hsu, John Hiemenz, Nosha Farhadfar, Erin A. Dean, John R. Wingard & Randy Brown
Published online: 06 Jun 2024
  • 6 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial
Vikas Gupta, Abdulraheem Yacoub, Ruben A. Mesa, Claire N. Harrison, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, Hans-Joachim Deeg, Salman Fazal, Lynda Foltz, Ryan J. Mattison, Carole B. Miller, Vinod Parameswaran, Patrick Brown, Christopher Hernandez, Jia Wang & Moshe Talpaz
Published online: 05 Jun 2024
  • 136 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Letter to the Editor

Letter to the Editor
A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Geoffrey Shouse, Lu Chen, Tanya Siddiqi, Alex Muir, Jennifer R. Brown, Stephen E. Spurgeon & Alexey V. Danilov
Published online: 05 Jun 2024
  • 12 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Tumor flare with T-cell-engaging bispecific antibodies
Carmelo Carlo-Stella, Michael J. Dickinson, Gloria Iacoboni, Cecilia Carpio, Natalie Dimier, Martin Weisser, Antonia Kwan & Cristiano Ferlini
Published online: 05 Jun 2024
  • 36 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Risk of SARS-CoV-2 infection and severe COVID-19 in hematological patients who received or not pre-exposure prophylaxis with tixagevimab/cilgavimab: a target trial emulation
Marco Falcone, Giusy Tiseo, Gabriele Marchetti, Jona Kalo, Valentina Galfo, Sara Occhineri, Francesco Almerigogna, Tommaso Matucci, Niccolò Riccardi, Lorenzo Roberto Suardi, Ines Rina, Ledja Sijoni, Maria Costanza Caparello, Raffaella Cassano Cassano, Maria Livia Del Giudice, Marinunzia Franciosa, Flaminia Facella, Gaspare Tancredi, Rita Fazzi & Sara Galimberti
Published online: 04 Jun 2024
  • 26 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Shift in first-line therapies for United States Veterans Affairs (VA) patients with chronic lymphocytic leukemia (CLL)
Christopher Raymond Frei, Kellie Ryan, Grace Oby Obodozie-Ofoegbu, Amanda Marie Moore, Chengwen Teng, Kana Tai Lucero, Laura Dean Davis, Xavier Francisco Jones & Zohra Nooruddin
Published online: 04 Jun 2024
  • 11 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Acute neurologic deterioration in a patient with asymptomatic Charcot-Marie-Tooth disease following three doses of Brentuximab-Vedotin
Haridian de la Nuez Melián, Hugo Luzardo Henríquez, Alexia Suárez Cabrera, Ruth Stuckey & María Teresa Gómez-Casares
Published online: 03 Jun 2024
  • 12 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasms
Blake Langlais, Amylou C. Dueck, Heidi E. Kosiorek, Carolyn Mead-Harvey, Eric Meek, Lauren Rogak, John Mascarenhas, Ruben Mesa, Krisstina Gowin, Jean Palmer, Robyn Scherber, Bridget Marcellino, Ronald Hoffman & Gina L. Mazza
Published online: 02 Jun 2024
  • 29 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Novel chemotherapy combination of carfilzomib with dexamethasone, cyclophosphamide, etoposide and cisplatin (K-DCEP) for the treatment of relapsed/refractory aggressive plasma cell dyscrasias
Charlotte B. Wagner, Kelley Julian, Baylee Bryan, Mary N. Steinbach, Samuel Shewan, Lindsay Maxwell, Meghan Vigil, Ghulam Rehman Mohyuddin, Amandeep Godara, Brian McClune, Glicelda Galarza Fortuna & Douglas Sborov
Published online: 02 Jun 2024
  • 43 Views
  • 0 CrossRef citations
  • 0Altmetric

Review Article

Review Article
MRD dynamics during maintenance therapy in 259 patients with nontransplant eligible multiple myeloma
Qian-qian Cui, Zhi-hua Li & Yan-ping Ma
Published online: 30 May 2024
  • 26 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Outcomes of patients aged ≥26 years with relapsed or refractory B-cell acute lymphoblastic leukemia in ZUMA-3 and historical trials
Monique C. Minnema, Xiang Yin, Ruthanna Davi, Sam Keeping, Julie E. Park, Taha Itani, Tsveta Hadjivassileva, Jean-Gabriel Castaigne, Rita Damico Khalid, Lang Zhou, James J. Wu & Bijal D. Shah
Published online: 24 May 2024
  • 334 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Letter to the Editor

Letter to the Editor
Acceleration of non-Hodgkin lymphoma progression during pregnancy in a murine model
Netanel A. Horowitz, Ali Abed Al Wahad, Noam P. Bettman, Shimrit Ringelstein-Harlev, Benjamin Brenner & Tami Katz
Published online: 23 May 2024
  • 26 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia
Karolina Bełdzińska-Gądek, Ewa Zarzycka, Krzysztof Pastuszak, Katarzyna Borman, Krzysztof Lewandowski, Jan M. Zaucha & Witold Prejzner
Published online: 22 May 2024
  • 61 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over- expressed MYC/BCL-2
Yang Liu, Xiaopeng Ma, Xikun Wu, Xinfeng Hou, Wei Jin, Lina Fu, Xiaolei Xun, Yiling Yu & Zhirong Shen
Published online: 22 May 2024
  • 320 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic): clinical review in a rapidly emerging field
Luan Phan, Danielle Hammond, Nathaniel R. Wilson, Emma M. Groarke, Mrinal M. Patnaik & Naveen Pemmaraju
Published online: 21 May 2024
  • 108 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Successful pregnancy outcome in a patient with myelofibrosis receiving ruxolitinib treatment in the first trimester
Ivana Urosevic, Marina Dokic, Ivanka Percic, Amir El Farra, Dunja Bjelogrlic & Borivoj Sekulic
Published online: 20 May 2024
  • 41 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation
Takashi Nagayama, Shin-ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Shuka Furuki, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Takashi Ikeda, Kazuki Hyodo, Shin-ichiro Kawaguchi, Yumiko Toda, Kento Umino, Daisuke Minakata, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine & Yoshinobu Kanda
Published online: 20 May 2024
  • 34 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Octreotide as prophylaxis against asparaginase-associated pancreatitis: a case series study
Hiroshi Hayashi, Yoshihiko Morikawa, Shogo Akahoshi, Kento Ikegawa, Motohiro Matsui, Atsushi Makimoto & Yuki Yuza
Published online: 20 May 2024
  • 36 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Experience in improving treatment outcomes for childhood acute lymphoblastic leukemia: real-world results for a province in China, 2011–2020
Yongzhi Zheng, Jiazheng Li, Hong Wen, Kaizhi Weng, Shuquan Zhuang, Xingguo Wu, Jian Li, Hao Zheng, Xueling Hua, Zaisheng Chen, Jianda Hu & Shaohua Le
Published online: 20 May 2024
  • 193 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di, Christopher T. Su, Andrew J. Cowan, Ajay K. Gopal & Rahul Banerjee
Published online: 15 May 2024
  • 184 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek, Wei-Ying Jen, Hagop M. Kantarjian, David McCue, Fadi G. Haddad, William Wierda, Alessandra Ferrajoli, Jan Burger, Tareq Abusab, Jeffrey Jorgensen, Sa A. Wang, Keyur Patel, Sanam Loghavi, Susan O’Brien & Farhad Ravandi
Published online: 15 May 2024
  • 95 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth, Jingjing Zhang, Timothy Miller, Joshua Menke, Jean Oak & Sebastian Fernandez-Pol
Published online: 15 May 2024
  • 30 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas, Maria Chaouki, Sandra de Barros, Baptiste Bonneau, Ben Allal, Julie Guillermet-Guibert & Loïc Ysebaert
Published online: 15 May 2024
  • 40 Views
  • 0 CrossRef citations
  • 0Altmetric

Correction

Correction
Correction
Published online: 14 May 2024
  • 31 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Letter to the Editor

Letter to the Editor
Treatment of methotrexate-refractory primary central nervous system lymphoma (PCNSL) at Memorial Sloan Kettering Cancer Center
Seena Cherian, Lisa Modelevsky, Anne S. Reiner & Christian Grommes
Published online: 14 May 2024
  • 72 Views
  • 0 CrossRef citations
  • 0Altmetric

Emerging Drug Profile

Emerging drug profile: JAK inhibitors
Alexander Coltoff & Andrew Kuykendall
Published online: 13 May 2024
  • 78 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
A de novo germline RUNX1 variant preceding development of concurrent T-lymphoblastic leukemia and myelodysplastic syndrome
Cassandra P. Wang, Juanita E. Ferreira, Alexander Placek, Paibel Aguayo-Hiraldo, Gordana Raca, Brent L. Wood, Karin P. Miller, Thomas Coates, David R. Freyer & Alexandra E. Kovach
Published online: 11 May 2024
  • 95 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study
Farhad Ravandi, Marion Subklewe, Roland B. Walter, Pankit Vachhani, Gert Ossenkoppele, Veit Buecklein, Hartmut Döhner, Mojca Jongen-Lavrencic, Claudia D. Baldus, Lars Fransecky, Timothy S. Pardee, Hagop Kantarjian, Priscilla K. Yen, Lata Mukundan, Bharat Panwar, Marc R. Yago, Suresh Agarwal, Sophia K. Khaldoyanidi & Anthony Stein
Published online: 07 May 2024
  • 137 Views
  • 0 CrossRef citations
  • 0Altmetric

Review Article

Review Article
Advances in the management of higher-risk myelodysplastic syndromes: future prospects
Georgina Gener-Ricos, Juan Jose Rodriguez-Sevilla, Samuel Urrutia, Alex Bataller, Alexandre Bazinet & Guillermo Garcia-Manero
Published online: 07 May 2024
  • 95 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide
Peter A. von dem Borne, Berit M. Kemps-Mols, Liesbeth C. de Wreede, Adriaan A. van Beek, Tjeerd J.F. Snijders, Daniëlle van Lammeren, Janneke Tijmensen, Aniko Sijs-Szabó, Mirjam A. Oudshoorn, Constantijn J.M Halkes, Peter van Balen, W.A. Erik Marijt, Jennifer M.L. Tjon, Joost S.P Vermaat & Hendrik Veelken
Published online: 06 May 2024
  • 309 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
Risk factors for treatment-related bone loss and osteoporosis in patients with follicular lymphoma
Yong Xing, Kaifeng Ye, Chunyuan Li, Jinyao He, Fei Dong & Yun Tian
Published online: 06 May 2024
  • 261 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study
Scott F. Huntington, Wendy Y. Cheng, Eric M. Sarpong, Siyang Leng, Mohammed Z. H. Farooqui, Uchechukwu Samuel Agu, Maryaline Catillon, Dominique Lejeune, Nathaniel Downes, Lisa Matay, Mei Sheng Duh & Enrico De Nigris
Published online: 02 May 2024
  • 418 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
BRAF mutation in myeloid neoplasm: incidences and clinical outcomes
Tareq Abuasab, Shehab Mohamed, Naveen Pemmaraju, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Farhad Ravandi, Wei Qiao, Guillermo Montalban-Bravo & Gautam Borthakur
Published online: 02 May 2024
  • 56 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Direct and indirect costs for patients with myeloproliferative neoplasms
Jingbo Yu, James Nelson, Taylor Marlin, Evan Braunstein & Michelle Jerry
Published online: 27 Apr 2024
  • 346 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
Targets and treatments in primary CNS lymphoma
Christina von Roemeling, Andrés J. M. Ferreri, Carole Soussain, Han W. Tun & Christian Grommes
Published online: 24 Apr 2024
  • 1177 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
George Nesr, Simone Claudiani, Dragana Milojkovic, Andrew Innes, Fiona Fernando, Irene Caballes, Patience Mungozi, Richard Szydlo, Silvia Lovato, Channa Jayasena & Jane Apperley
Published online: 23 Apr 2024
  • 510 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
Challenges in management of older patients with chronic myeloid leukemia
Jessica M. Stempel, Rory M. Shallis, Rong Wong & Nikolai A. Podoltsev
Published online: 23 Apr 2024
  • 114 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3-mutant acute myeloid leukemia
Jan Philipp Bewersdorf, Kishan K. Patel, Rory M. Shallis, Nikolai A. Podoltsev, Tariq Kewan, Jessica Stempel, Lourdes Mendez, Maximilian Stahl, Eytan M. Stein, Scott F. Huntington, George Goshua & Amer M. Zeidan
Published online: 22 Apr 2024
  • 116 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter?
Gretchen A. McNally, Connor M. Aossey, Tracy Wiczer, Loraine T. Sinnott, Mark Lustberg, Robert A. Baiocchi & Maryam Lustberg
Published online: 22 Apr 2024
  • 474 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
Evaluating targeted therapies in older patients with TP53-mutated AML
Jean M.G. Sabile, Ronan Swords & Jeffrey W. Tyner
Published online: 22 Apr 2024
  • 153 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Evaluation of safety outcomes with transitioning obinutuzumab from standard rate to short duration infusion in patients with chronic lymphocytic leukemia
Caroline Fleck, Allison Karabinos, Allene Cook, Donald C. Moore & Ryan Jacobs
Published online: 22 Apr 2024
  • 42 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Light-chain-restricted Russell body oral mucositis: an immunohistochemical study and literature review
Luana Stefanie Silvino Gonçalves, Karina Helen Martins, Magdalena Raquel Torres Reyes, Isabella Silva Catananti, Fernando Chahud & Jorge Esquiche León
Published online: 18 Apr 2024
  • 97 Views
  • 0 CrossRef citations
  • 0Altmetric

Review Article

Review Article
Management of relapsed/refractory mantle cell lymphoma
Musa Alzahrani & Diego Villa
Published online: 18 Apr 2024
  • 176 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy
Jose Tinajero, Dat Ngo, Jianying Zhang, Ni-Chun Tsai, Ahmed Aribi, Ibrahim Aldoss, Vaibhav Agrawal, Shukaib Arslan, Idoroenyi Amanam, Hoda Pourhassan, Karamjeet Sandhu, Monzr Al-Malki, Vinod Pullarkat, Pamela Becker, Ryotaro Nakamura, Anthony Stein, Guido Marcucci, Andrew Artz, Paul Koller & Amandeep Salhotra
Published online: 18 Apr 2024
  • 47 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study
Ibrahim Aldoss, Jianying Zhang, Marjorie Robbins, Joo Song, Monzr M. Al Malki, Salman Otoukesh, Karamjeet Sandhu, Vaibhav Agrawal, Alex F. Herrera, Leslie L. Popplewell, Lucy Ghoda, Anthony Stein, Guido Marcucci, Stephen Forman & Vinod Pullarkat
Published online: 17 Apr 2024
  • 67 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
COVID-19 antibody titers after tixagevimab–cilgavimab injection in patients with hematologic diseases; a single-center, prospective study
Naokazu Nakamura, Hiroko Tsunemine, Ryo Ikunari, Tomomi Sakai & Nobuyoshi Arima
Published online: 16 Apr 2024
  • 33 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)
Imran Haider, Darryl P. Leong, Martha Louzada, Arleigh McCurdy, Gregory R. Pond, Ruthanne Cameron, Mohammed Aljama, Alissa Visram, Tanya M. Wildes & Hira Mian
Published online: 16 Apr 2024
  • 77 Views
  • 0 CrossRef citations
  • 0Altmetric
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days